Latest news
Can DaVita’s (DVA) Better Mortality Trends Redefine Its Core Dialysis Investment Story? - simplywall.stsimplywall.st · Fri, 07 Aug 2026 05:36:48 GMTDVA Q2 Deep Dive: Flat Volumes and Policy Transitions Shape Outlook - StockStoryStockStory · Wed, 05 Aug 2026 17:24:09 GMTRoche-backed Mironid gets $46M boost to put rare kidney disease drug on path to clinic - FirstWord PharmaFirstWord Pharma · Wed, 05 Aug 2026 08:06:57 GMT